Should high risk patients with concomitant severe aortic stenosis and mitral valve disease undergo double valve surgery in the TAVR era?

• Published in: Journal of cardiothoracic surgery 2017-12, Vol.12 (1), p.123-123, Article 123
• Main Authors: Yu, Pey-Jen, Mattia, Allan, Cassiere, Hugh A, Esposito, Rick, Manetta, Frank, Kohn, Nina, Hartman, Alan R
• Format: Article
• Language: English
• Subjects: Aortic stenosis; Aortic valve stenosis; Aortic valve surgery; Cardiac patients; Health aspects; Lung diseases; Mitral valve surgery; Mortality; Risk factors; Transcatheter aortic valve replacement
• ISSN: 1749-8090; 1749-8090
• DOI: 10.1186/s13019-017-0688-z

Significant mitral regurgitation in patients undergoing transcatheter aortic valve replacement (TAVR) is associated with increased mortality. The aim of this study is to determine if surgical correction of both aortic and mitral valves in high risk patients with concomitant valvular disease would offer patients better outcomes than TAVR alone. A retrospective analysis of 43 high-risk patients who underwent concomitant surgical aortic valve replacement and mitral valve surgery from 2008 to 2012 was performed. Immediate and long term survival were assessed. There were 43 high-risk patients with severe aortic stenosis undergoing concomitant surgical aortic valve replacement and mitral valve surgery. The average age was 80 ± 6 years old. Nineteen (44%) patients had prior cardiac surgery, 15 (34.9%) patients had chronic obstructive lung disease, and 39 (91%) patients were in congestive heart failure. The mean Society of Thoracic Surgeons Predicted Risk of Mortality for isolated surgical aortic valve replacement for the cohort was 10.1% ± 6.4%. Five patients (11.6%) died during the index admission and/or within thirty days of surgery. Mortality rate was 25% at six months, 35% at 1 year and 45% at 2 years. There was no correlation between individual preoperative risk factors and mortality. High-risk patients with severe aortic stenosis and mitral valve disease undergoing concomitant surgical aortic valve replacement and mitral valve surgery may have similar long term survival as that described for such patients undergoing TAVR. Surgical correction of double valvular disease in this patient population may not confer mortality benefit compared to TAVR alone.